Arbutus Biopharma Corp · Cash & Short-Term Investments

Latest reported$91.47Mperiod endingDec 31, 2025

ABUS FY Cash & Short-Term Investments ($6.46M → $91.47M)

Annual Cash & Short-Term Investments

High-resolution chart · PNG

ABUS cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Arbutus Biopharma Corp Cash & Short-Term Investments — Annual fiscal periods (USD)
Period ending	Cash & Short-Term Investments (USD)
Dec 31, 2025	91,471,000
Dec 31, 2024	122,623,000
Dec 31, 2023	126,003,000
Dec 31, 2022	146,913,000
Dec 31, 2021	155,317,000
Dec 31, 2020	123,268,000
Dec 31, 2019	90,834,000
Dec 31, 2018	124,617,000
Dec 31, 2017	126,400,000
Dec 31, 2016	130,500,000
Dec 31, 2015	181,304,000
Dec 31, 2014	112,200,000
Dec 31, 2013	68,716,531
Dec 31, 2012	47,028,656
Dec 31, 2011	8,995,234
Dec 31, 2010	12,344,034
Dec 31, 2009	23,300,296
Dec 31, 2008	26,252,135
Dec 31, 2007	21,130,481
Dec 31, 2006	4,865,089
Dec 31, 2005	10,481,334
Dec 31, 2004	24,993,574
Dec 31, 2003	39,205,133
Dec 31, 2002	38,171,318
Dec 31, 2001	47,562,458
Dec 31, 2000	23,973,740
Dec 31, 1999	19,614,649
Dec 31, 1998	6,457,475